BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16871252)

  • 1. Myostatin and insulin-like growth factors in uremic sarcopenia: the yin and yang in muscle mass regulation.
    Mak RH; Rotwein P
    Kidney Int; 2006 Aug; 70(3):410-2. PubMed ID: 16871252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Work-induced changes in skeletal muscle IGF-1 and myostatin gene expression in uremia.
    Sun DF; Chen Y; Rabkin R
    Kidney Int; 2006 Aug; 70(3):453-9. PubMed ID: 16871256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of melanocortin signaling ameliorates uremic cachexia.
    Cheung WW; Rosengren S; Boyle DL; Mak RH
    Kidney Int; 2008 Jul; 74(2):180-6. PubMed ID: 18432186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myostatin, insulin-like growth factor-1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy.
    Reardon KA; Davis J; Kapsa RM; Choong P; Byrne E
    Muscle Nerve; 2001 Jul; 24(7):893-9. PubMed ID: 11410916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy.
    Gilson H; Schakman O; Combaret L; Lause P; Grobet L; Attaix D; Ketelslegers JM; Thissen JP
    Endocrinology; 2007 Jan; 148(1):452-60. PubMed ID: 17038559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle mRNA for IGF-IEa, IGF-II, and IGF-I receptor is decreased in sedentary chronic hemodialysis patients.
    Wang H; Casaburi R; Taylor WE; Aboellail H; Storer TW; Kopple JD
    Kidney Int; 2005 Jul; 68(1):352-61. PubMed ID: 15954927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentrations of insulin-like growth factor-1, members of the TGF-beta superfamily and follistatin do not reflect different stages of dynapenia and sarcopenia in elderly women.
    Hofmann M; Halper B; Oesen S; Franzke B; Stuparits P; Tschan H; Bachl N; Strasser EM; Quittan M; Ploder M; Wagner KH; Wessner B
    Exp Gerontol; 2015 Apr; 64():35-45. PubMed ID: 25681638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged absence of myostatin reduces sarcopenia.
    Siriett V; Platt L; Salerno MS; Ling N; Kambadur R; Sharma M
    J Cell Physiol; 2006 Dec; 209(3):866-73. PubMed ID: 16972257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of exercise on mRNA levels for growth factors in skeletal muscle of hemodialysis patients.
    Kopple JD; Cohen AH; Wang H; Qing D; Tang Z; Fournier M; Lewis M; Casaburi R; Storer T
    J Ren Nutr; 2006 Oct; 16(4):312-24. PubMed ID: 17046615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of insulin, insulin-like growth factors, and muscle regulatory factors in the compensatory growth of the trout (Oncorhynchus mykiss).
    Montserrat N; Gabillard JC; Capilla E; Navarro MI; Gutiérrez J
    Gen Comp Endocrinol; 2007 Feb; 150(3):462-72. PubMed ID: 17196198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myostatin is a procachectic growth factor during postnatal myogenesis.
    McFarlane C; Sharma M; Kambadur R
    Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):422-7. PubMed ID: 18542002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms involving IGF-1 and myostatin to induce muscle hypertrophy as a therapeutic strategy for Duchenne muscular dystrophy.
    Patel K; Macharia R; Amthor H
    Acta Myol; 2005 Dec; 24(3):230-41. PubMed ID: 16629058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of muscle mass by myostatin.
    Lee SJ
    Annu Rev Cell Dev Biol; 2004; 20():61-86. PubMed ID: 15473835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myostatin and its precursor protein are increased in the skeletal muscle of patients with Type-II muscle fibre atrophy.
    Wójcik S; Nogalska A; Engel WK; Askanas V
    Folia Morphol (Warsz); 2008 Feb; 67(1):6-12. PubMed ID: 18335407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The growth factor myostatin, a key regulator in skeletal muscle growth and homeostasis.
    Matsakas A; Diel P
    Int J Sports Med; 2005 Mar; 26(2):83-9. PubMed ID: 15726494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy with anabolic growth factors to prevent muscle atrophy.
    Schakman O; Thissen JP
    Curr Opin Clin Nutr Metab Care; 2006 May; 9(3):207-13. PubMed ID: 16607118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Inhibitory Core of the Myostatin Prodomain: Its Interaction with Both Type I and II Membrane Receptors, and Potential to Treat Muscle Atrophy.
    Ohsawa Y; Takayama K; Nishimatsu S; Okada T; Fujino M; Fukai Y; Murakami T; Hagiwara H; Itoh F; Tsuchida K; Hayashi Y; Sunada Y
    PLoS One; 2015; 10(7):e0133713. PubMed ID: 26226340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis and myostatin mRNA are upregulated in the skeletal muscle of patients with chronic kidney disease.
    Verzola D; Procopio V; Sofia A; Villaggio B; Tarroni A; Bonanni A; Mannucci I; De Cian F; Gianetta E; Saffioti S; Garibotto G
    Kidney Int; 2011 Apr; 79(7):773-82. PubMed ID: 21228768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postnatal expression of myostatin propeptide cDNA maintained high muscle growth and normal adipose tissue mass in transgenic mice fed a high-fat diet.
    Yang J; Zhao B
    Mol Reprod Dev; 2006 Apr; 73(4):462-9. PubMed ID: 16437538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myostatin and MyoD family expression in skeletal muscle of IGF-1 knockout mice.
    Miyake M; Hayashi S; Sato T; Taketa Y; Watanabe K; Hayashi S; Tanaka S; Ohwada S; Aso H; Yamaguchi T
    Cell Biol Int; 2007 Oct; 31(10):1274-9. PubMed ID: 17590360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.